Zhong Yuan Bio-Technology Holdings Limited
Zhong Yuan Bio-Technology Holdings Limited engages in the sale of plant-derived nervonic acid dietary supplements in China. It operates through four segments: Sales of Dietary Supplements; Research and Development Services; Royalties; and Event Organization. It also develops early detection kits for brain diseases and new drugs for neurological diseases; and technical supporting services. It sell… Read more
Zhong Yuan Bio-Technology Holdings Limited (ZHYBF) - Total Assets
Latest total assets as of September 2024: $3.17 Million USD
Based on the latest financial reports, Zhong Yuan Bio-Technology Holdings Limited (ZHYBF) holds total assets worth $3.17 Million USD as of September 2024.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Zhong Yuan Bio-Technology Holdings Limited - Total Assets Trend (2018–2025)
This chart illustrates how Zhong Yuan Bio-Technology Holdings Limited’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Zhong Yuan Bio-Technology Holdings Limited - Asset Composition Analysis
Current Asset Composition (March 2025)
Zhong Yuan Bio-Technology Holdings Limited's total assets of $3.17 Million consist of 64.0% current assets and 36.1% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 4.6% |
| Accounts Receivable | $1.47 Million | 46.4% |
| Inventory | $29.66K | 0.9% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2018–2025)
This chart illustrates how Zhong Yuan Bio-Technology Holdings Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Zhong Yuan Bio-Technology Holdings Limited's current assets represent 64.0% of total assets in 2025, a decrease from 100.0% in 2018.
- Cash Position: Cash and equivalents constituted 4.6% of total assets in 2025, down from 100.0% in 2018.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2018.
- Asset Diversification: The largest asset category is accounts receivable at 46.4% of total assets.
Zhong Yuan Bio-Technology Holdings Limited Competitors by Total Assets
Key competitors of Zhong Yuan Bio-Technology Holdings Limited based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
General Mills Inc
NYSE:GIS
|
USA | $32.55 Billion |
|
B&G Foods Inc
NYSE:BGS
|
USA | $2.94 Billion |
|
Tangrenshen Group Co Ltd
SHE:002567
|
China | CN¥17.90 Billion |
|
Shenzhen Shenbao Industrial Co Ltd
SHE:000019
|
China | CN¥7.01 Billion |
|
Xiwang Foodstuffs Co Ltd
SHE:000639
|
China | CN¥6.08 Billion |
|
Nanfang Black Sesame Group Co Ltd
SHE:000716
|
China | CN¥4.57 Billion |
|
CNFC Overseas Fishery Co Ltd
SHE:000798
|
China | CN¥5.88 Billion |
|
Henan Shuanghui Investment & Development Co Ltd
SHE:000895
|
China | CN¥40.64 Billion |
Zhong Yuan Bio-Technology Holdings Limited - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Zhong Yuan Bio-Technology Holdings Limited generates 0.72x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Solid ROA - For every $100 in assets, Zhong Yuan Bio-Technology Holdings Limited generates $9.54 in net profit.
Zhong Yuan Bio-Technology Holdings Limited - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.82 | 0.87 | 13.03 |
| Quick Ratio | 0.80 | 0.83 | 11.38 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-456.51K | $ -308.69K | $ 1.56 Million |
Zhong Yuan Bio-Technology Holdings Limited - Advanced Valuation Insights
This section examines the relationship between Zhong Yuan Bio-Technology Holdings Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 348.83 |
| Latest Market Cap to Assets Ratio | 2.26 |
| Asset Growth Rate (YoY) | 0.0% |
| Total Assets | $3.17 Million |
| Market Capitalization | $7.15 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values Zhong Yuan Bio-Technology Holdings Limited's assets at a significant premium ( 2.26x), suggesting investors see substantial growth potential or unique competitive advantages.
Slight Asset Contraction: Zhong Yuan Bio-Technology Holdings Limited's assets decreased by 0.0% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Zhong Yuan Bio-Technology Holdings Limited (2018–2025)
The table below shows the annual total assets of Zhong Yuan Bio-Technology Holdings Limited from 2018 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-03-31 | $3.17 Million | 0.00% |
| 2024-03-31 | $3.17 Million | +38.93% |
| 2023-03-31 | $2.28 Million | -20.07% |
| 2022-03-31 | $2.85 Million | -17.49% |
| 2021-03-31 | $3.46 Million | +51.69% |
| 2020-03-31 | $2.28 Million | +21.52% |
| 2019-03-31 | $1.88 Million | +1875618.00% |
| 2018-03-31 | $100.00 | -- |